# Pharmacokinetic, Safety and Tolerability Study of Altebrel in Healthy Male Subjects

> **NCT03273088** · PHASE1 · COMPLETED · sponsor: **AryoGen Pharmed Co.** · enrollment: 34 (actual)

## Conditions studied

- Phase 1
- Bioequivalence

## Interventions

- **DRUG:** Etanercept

## Key facts

- **NCT ID:** NCT03273088
- **Lead sponsor:** AryoGen Pharmed Co.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-04
- **Primary completion:** 2017-03-15
- **Final completion:** 2017-03-15
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2018-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03273088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03273088, "Pharmacokinetic, Safety and Tolerability Study of Altebrel in Healthy Male Subjects". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03273088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*